Aerosol delivery devices and obstructive airway disease
Author: O’’Riordan, Thomas G
Source: Expert Review of Medical Devices, 1 March 2005, vol. 2, no. 2, pp. 197-203(7)
Abstract:Two obstructive lung diseases, asthma and chronic obstructive pulmonary disease, account for the vast majority of prescriptions for aerosolized medications and devices. Asthma is an immunologically mediated condition characterized by episodic reversible airway obstructions that occur in all age groups. In contrast, chronic obstructive pulmonary disease is a condition characterized by relatively irreversible obstruction that is seen in middle-aged and elderly cigarette smokers. Nevertheless, there is sufficient overlap in terms of airway physiology and therapeutics to allow a review of the challenge of aerosol delivery in both conditions in the same article. This review will concentrate on issues related to aerosol delivery.
Document Type: Research Article
Publication date: 2005-03-01T00:00:00